Stockreport

Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF eventually compete with market-leading medicines from Novo Nordisk and Eli Lilly. In its first official announcement, the biotech, whose existence was revealed by Endp [Read more]